Dose-attenuated radioimmunotherapy with tositumomab and iodine 131 tositumomab in patients with recurrent non-Hodgkin's lymphoma (NHL) and extensive bone marrow involvement-Reference-Cited by-同舟云学术

Dose-attenuated radioimmunotherapy with tositumomab and iodine 131 tositumomab in patients with recurrent non-Hodgkin's lymphoma (NHL) and extensive bone marrow involvement

Published:2007-01 Issue:2 Volume:48 Page:342-348
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Mones Jodi V.,Coleman Morton,Kostakoglu Lale,Furman Richard R.,Chadburn Amy,Shore Tsiporah B.,Muss Daniel,Stewart Patricia,Kroll Stewart,Vallabhajosula Shankar,Goldsmith Stanley J.,Leonard John P.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190601059720

Reference32 articles.

1. The Natural History of Initially Untreated Low-Grade Non-Hodgkin's Lymphomas

2. Cancer Surveillance Series: Non-Hodgkin's Lymphoma Incidence by Histologic Subtype in the United States From 1978 Through 1995

3. Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Basics and Clinical Applications of Radioimmunotherapy;Radionuclide Therapy;2022

2. Radioimmunotherapy of human tumours;Nature Reviews Cancer;2015-05-22

3. The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy;European Journal of Nuclear Medicine and Molecular Imaging;2014-06-11

4. Radioimmunotherapy for B-Cell Non-Hodgkin Lymphoma;Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer;2010-07-15

5. Biological therapy of B and T cell lymphoproliferative disorders;Principles of Cancer Biotherapy;2009